- QBI researchers have discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis of the disorder.
- QBI researchers have discovered a molecule that protects brain cells from oxidative stress and damage, opening new avenues for possible treatments for brain diseases.
- NuNerve, a company formed to commercialise research from UQ’s Queensland Brain Institute, has produced successful results in a human clinical trial for potential new treatment for MND.
Pages
Impact Report 2023/2024
Thank you for your generosity and the hope you instil in us through your support of QBI's research. Together, we have been able to propel discoveries and push the boundaries of human knowledge about the brain.
Engage
General enquiries
+61 7 334 66300
qbi@uq.edu.au
Student enquiries
HDR students
Higher Degree by Research Liaison Officer
+61 7 334 66401 (Mon, Tue, Fri)
hdr.qbi@enquire.uq.edu.au
All other students
Collaborators Liaison
+61 7 334 66300
collaborators@qbi.uq.edu.au